A) | |||||
---|---|---|---|---|---|
Cohort 1 | Typ | Number | FIGO | Age ± SD [years] | Range [years] |
Controls | Healthy | 90 | n. a. | 46.7 ± 16.8 | 19 - 83 |
Cystadenoma | 6 | n. a. | 57.3 ± 8.5 | 45 - 66 | |
LMP | 8 | n. a. | 60.0 ± 18.6 | 32 - 92 | |
Malignant disease | Ovarian cancer | 19 | FIGO I-II | 55.5 ± 16.7 | 15 - 85 |
220 | FIGO III-IV | 58.6 ± 11.8 | 18 - 83 | ||
Cohort 2 | |||||
Controls | Healthy | 30 | n. a. | ||
Benign gynecological diseases | 35 | n. a. | 47.3 ± 13.2 | 25 - 74 | |
Malignant disease (overlapping with cohort 1) | Ovarian Cancer | 14 | FIGO I-II | ||
210 | FIGO III-IV | ||||
B) | |||||
FIGO I-II patients | 19 | ||||
Histology | |||||
Serous | 14 | ||||
Endometrioid | 2 | ||||
Mucinous | 1 | ||||
Undifferentiated | 2 | ||||
FIGO | |||||
Ia | 2 | ||||
Ic | 7 | ||||
IIa | 4 | ||||
IIb | 2 | ||||
IIc | 4 | ||||
Grade (1 missing) | |||||
1 | 4 | ||||
2 | 6 | ||||
3 | 8 | ||||
FIGO III-IV patients | 220 | ||||
Histology (1 missing) | |||||
Serous | 194 | ||||
Endometrioid | 4 | ||||
Mucinous | 3 | ||||
Undifferentiated | 6 | ||||
Mixed epithelial | 12 | ||||
FIGO (3 missing) | |||||
IIIa | 4 | ||||
IIIb | 7 | ||||
IIIc | 166 | ||||
IV | 40 | ||||
Grade (4 missing) | |||||
1 | 8 | ||||
2 | 51 | ||||
3 | 157 | ||||
C) | |||||
Benign diseases | 35 | ||||
Cystadenoma (mucinous) | 9 | ||||
Endometriosis | 5 | ||||
Ovarian fibroma | 2 | ||||
Uterine myoma | 9 | ||||
Miscellaneous (two with inflammatory conditions) | 10 |